Blockchain Registration Transaction Record

HeartBeam's 3D ECG Technology Achieves Major Milestone in Clinical Study

HeartBeam (NASDAQ: BEAT) announces successful validation of 3D ECG technology in pivotal study, achieving high diagnostic agreement with standard ECGs. Dr. Thomas Deering presents results at Heart Rhythm Society conference. Groundbreaking technology aims to bring hospital-grade cardiac insights to patients anywhere, redefining cardiac health management.

This news highlights the groundbreaking success of HeartBeam's innovative 3D ECG technology, which could revolutionize cardiac care by enabling portable, cable-free 12-lead ECGs for patients outside medical facilities. The high diagnostic agreement with standard ECGs is a significant step towards bringing advanced cardiac insights directly to patients, potentially transforming how cardiac health is managed and diagnosed.